Sanofi (NEO:SAN)
Canada flag Canada · Delayed Price · Currency is CAD
10.42
0.00 (0.00%)
Apr 27, 2026, 9:30 AM EST

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of CAD 152.22 billion. The enterprise value is 175.88 billion.

Market Cap 152.22B
Enterprise Value 175.88B

Important Dates

The last earnings date was Thursday, April 23, 2026.

Earnings Date Apr 23, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -2.73%
Shares Change (QoQ) -0.70%
Owned by Insiders (%) 0.02%
Owned by Institutions (%) 47.34%
Float 1.09B

Valuation Ratios

The trailing PE ratio is 12.52 and the forward PE ratio is 9.23.

PE Ratio 12.52
Forward PE 9.23
PS Ratio 2.00
PB Ratio 1.29
P/TBV Ratio 25.41
P/FCF Ratio 11.03
P/OCF Ratio 9.15
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.53, with an EV/FCF ratio of 12.74.

EV / Earnings 14.47
EV / Sales 2.32
EV / EBITDA 8.53
EV / EBIT 11.57
EV / FCF 12.74

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.27.

Current Ratio 1.01
Quick Ratio 0.20
Debt / Equity 0.27
Debt / EBITDA 1.53
Debt / FCF 2.33
Interest Coverage 18.84

Financial Efficiency

Return on equity (ROE) is 6.43% and return on invested capital (ROIC) is 9.38%.

Return on Equity (ROE) 6.43%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 9.38%
Return on Capital Employed (ROCE) 9.90%
Weighted Average Cost of Capital (WACC) 5.33%
Revenue Per Employee 1.02M
Profits Per Employee 162,457
Employee Count 74,846
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Sanofi has paid 1.58 billion in taxes.

Income Tax 1.58B
Effective Tax Rate 16.83%

Stock Price Statistics

Beta (5Y) 0.32
52-Week Price Change n/a
50-Day Moving Average 10.56
200-Day Moving Average n/a
Relative Strength Index (RSI) 51.52
Average Volume (20 Days) 11,518

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Sanofi had revenue of CAD 76.21 billion and earned 12.16 billion in profits. Earnings per share was 9.98.

Revenue 76.21B
Gross Profit 55.15B
Operating Income 15.62B
Pretax Income 9.39B
Net Income 12.16B
EBITDA 20.64B
EBIT 15.62B
Earnings Per Share (EPS) 9.98

Balance Sheet

The company has 8.92 billion in cash and 32.22 billion in debt, giving a net cash position of -23.30 billion.

Cash & Cash Equivalents 8.92B
Total Debt 32.22B
Net Cash -23.30B
Net Cash Per Share n/a
Equity (Book Value) 117.72B
Book Value Per Share 97.31
Working Capital 251.07M

Cash Flow

In the last 12 months, operating cash flow was 16.64 billion and capital expenditures -2.84 billion, giving a free cash flow of 13.81 billion.

Operating Cash Flow 16.64B
Capital Expenditures -2.84B
Depreciation & Amortization 4.99B
Net Borrowing 2.40B
Free Cash Flow 13.81B
FCF Per Share n/a

Margins

Gross margin is 72.36%, with operating and profit margins of 20.49% and 15.95%.

Gross Margin 72.36%
Operating Margin 20.49%
Pretax Margin 12.32%
Profit Margin 15.95%
EBITDA Margin 27.09%
EBIT Margin 20.49%
FCF Margin 18.11%

Dividends & Yields

Sanofi does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 63.16%
Buyback Yield 2.73%
Shareholder Yield 2.73%
Earnings Yield 7.99%
FCF Yield 9.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4